5 Biotech Stocks to Buy According to Billionaire David E. Shaw

3. Pfizer Inc. (NYSE:PFE)

D.E. Shaw’s Stake Value: $196 million

Percentage of D.E. Shaw’s 13F Portfolio: 0.16%

Number of Hedge Fund Holders: 85

Pfizer Inc. (NYSE:PFE) is an American pharmaceutical and biotechnology firm that is headquartered in New York. Its treatments and products cover diseases related to cardiovascular health, various infections such as COVID-19, inflammatory diseases, and endocrine diseases.

At the end of the fourth quarter of last year, Dr. Shaw’s investment firm owned 3.32 million Pfizer Inc. (NYSE:PFE) shares that were worth $196 million and represented 0.16% of its 13F investment portfolio’s value. At the same time, 85 hedge funds tracked by Insider Monkey held stakes in the company. Pfizer Inc. (NYSE:PFE)’s largest investor among those 85 funds was Philippe Laffont’s Coatue Management, which owned 10.3 million shares worth $609 million.

Pfizer Inc. (NYSE:PFE) reported $23.84 billion in revenue and $1.08 in non-GAAP EPS for its fiscal Q4, beating analysts’ EPS estimates but missing them for revenue. In a major development last month, the United States Food and Drug Administration (FDA) approved a second booster dose of the company’s coronavirus vaccine for older adults.